Last10K.com

Braskem Sa (BAK) SEC Filing 20-F Annual Report for the fiscal year ending Thursday, December 31, 2020

Braskem Sa

CIK: 1071438 Ticker: BAK

View differences made from one year to another to evaluate Braskem Sa's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 20-F Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Braskem Sa.

Continue

Assess how Braskem Sa's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Braskem Sa's Definitive Proxy Statement (Form DEF 14A) filed after their 2021 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 20-F Annual Report

Cover
Statement Of Consolidated Cash Flows
Statement Of Consolidated Changes In Equity
Statement Of Consolidated Comprehensive Income
Statement Of Consolidated Financial Position
Statement Of Consolidated Profit Or Loss
1 Operations
1 Operations (Details Narrative)
10 Taxes Recoverable
10 Taxes Recoverable (Details Narrative)
10 Taxes Recoverable (Details)
10 Taxes Recoverable (Tables)
11 Investments
11 Investments (Details 1)
11 Investments (Details 2)
11 Investments (Details 3)
11 Investments (Details 4)
11 Investments (Details Narrative)
11 Investments (Details)
11 Investments (Tables)
12 Property, Plant And Equipment
12 Property, Plant And Equipment (Details 1)
12 Property, Plant And Equipment (Details Narrative)
12 Property, Plant And Equipment (Details)
12 Property, Plant And Equipment (Tables)
13 Intangible Assets
13 Intangible Assets (Details 1)
13 Intangible Assets (Details 2)
13 Intangible Assets (Details 3)
13 Intangible Assets (Details Narrative)
13 Intangible Assets (Details)
13 Intangible Assets (Tables)
14 Right-Of-Use Assets And Lease Liability
14 Right-Of-Use Assets And Lease Liability (Details 1)
14 Right-Of-Use Assets And Lease Liability (Details 2)
14 Right-Of-Use Assets And Lease Liability (Details Narrative)
14 Right-Of-Use Assets And Lease Liability (Details)
14 Right-Of-Use Assets And Lease Liability (Table)
15 Trade Account Payables
15 Trade Account Payables (Details Narrative)
15 Trade Account Payables (Details)
15 Trade Account Payables (Tables)
16 Borrowings
16 Borrowings (Details 1)
16 Borrowings (Details 2)
16 Borrowings (Details 3)
16 Borrowings (Details 4)
16 Borrowings (Details 5)
16 Borrowings (Details 6)
16 Borrowings (Details Narrative)
16 Borrowings (Details)
16 Borrowings (Tables)
17 Braskem Idesa Financing
17 Braskem Idesa Financing (Details 1)
17 Braskem Idesa Financing (Details Narrative)
17 Braskem Idesa Financing (Details)
17 Braskem Idesa Financing (Tables)
18 Debentures
18 Debentures (Details 1)
18 Debentures (Details)
18 Debentures (Tables)
19 Reconciliation Of Borrowing Activities In The Statement Of Cash Flow (Details)
19 Reconciliation Of Borrowing Activities In The Statement Of Cash Flow (Tables)
19 Reconciliation Of Financing Activities In Statement Of Cash Flow
2 Accounting Policies
2 Accounting Policies (Details 1)
2 Accounting Policies (Details 2)
2 Accounting Policies (Details Narrative)
2 Accounting Policies (Details)
2 Accounting Policies (Policies)
2 Accounting Policies (Tables)
20 Financial Instruments
20 Financial Instruments (Details 1)
20 Financial Instruments (Details 10)
20 Financial Instruments (Details 11)
20 Financial Instruments (Details 12)
20 Financial Instruments (Details 13)
20 Financial Instruments (Details 14)
20 Financial Instruments (Details 15)
20 Financial Instruments (Details 16)
20 Financial Instruments (Details 17)
20 Financial Instruments (Details 18)
20 Financial Instruments (Details 19)
20 Financial Instruments (Details 2)
20 Financial Instruments (Details 20)
20 Financial Instruments (Details 21)
20 Financial Instruments (Details 3)
20 Financial Instruments (Details 4)
20 Financial Instruments (Details 5)
20 Financial Instruments (Details 6)
20 Financial Instruments (Details 7)
20 Financial Instruments (Details 8)
20 Financial Instruments (Details 9)
20 Financial Instruments (Details Narrative)
20 Financial Instruments (Details)
20 Financial Instruments (Tables)
21 Taxes Payable
21 Taxes Payable (Details)
21 Taxes Payable (Tables)
22 Income Tax (''Ir'') And Social Contribution (''Csl'')
22 Income Tax (''Ir'') And Social Contribution (''Csl'') (Details 1)
22 Income Tax (''Ir'') And Social Contribution (''Csl'') (Details 2)
22 Income Tax (''Ir'') And Social Contribution (''Csl'') (Details 3)
22 Income Tax (''Ir'') And Social Contribution (''Csl'') (Details 4)
22 Income Tax (''Ir'') And Social Contribution (''Csl'') (Details Narrative)
22 Income Tax (''Ir'') And Social Contribution (''Csl'') (Details)
22 Income Tax (''Ir'') And Social Contribution (''Csl'') (Tables)
23 Sundry Provisions
23 Sundry Provisions (Details 1)
23 Sundry Provisions (Details)
23 Sundry Provisions (Tables)
24 Contingencies
24 Contingencies (Details 1)
24 Contingencies (Details 2)
24 Contingencies (Details Narrative)
24 Contingencies (Details)
24 Contingencies (Tables)
25 Leniency Agreement
25 Leniency Agreement (Details Narrative)
26 Geological Event - Alagoas
26 Geological Event - Alagoas (Details Narrative)
26 Geological Event - Alagoas (Details)
26 Geological Event - Alagoas (Tables)
27 Benefits Offered To Team Members
27 Benefits Offered To Team Members (Details 1)
27 Benefits Offered To Team Members (Details 2)
27 Benefits Offered To Team Members (Details 3)
27 Benefits Offered To Team Members (Details 4)
27 Benefits Offered To Team Members (Details 5)
27 Benefits Offered To Team Members (Details 6)
27 Benefits Offered To Team Members (Details 7)
27 Benefits Offered To Team Members (Details Narrative)
27 Benefits Offered To Team Members (Details)
27 Benefits Offered To Team Members (Tables)
28 Equity
28 Equity (Details 1)
28 Equity (Details 2)
28 Equity (Details 3)
28 Equity (Details Narrative)
28 Equity (Details)
28 Equity (Tables)
29 Earnings Per Share
29 Earnings Per Share (Details 1)
29 Earnings Per Share (Details)
29 Earnings Per Share (Tables)
3 Application Of Critical Estimates And Judgments
3 Application Of Critical Estimates And Judgments (Details Narrative)
3 Application Of Critical Estimates And Judgments (Details)
3 Application Of Critical Estimates And Judgments (Tables)
30 Net Revenues
30 Net Revenues (Details 1)
30 Net Revenues (Details 2)
30 Net Revenues (Details Narrative)
30 Net Revenues (Details)
30 Net Revenues (Tables)
31 Tax Incentives
31 Tax Incentives (Details Narrative)
32 Other Income (Expenses), Net
32 Other Income (Expenses), Net (Details Narrative)
32 Other Income (Expenses), Net (Details)
32 Other Income (Expenses), Net (Tables)
33 Financial Results
33 Financial Results (Details)
33 Financial Results (Tables)
34 Expenses By Nature And Function
34 Expenses By Nature And Function (Details)
34 Expenses By Nature And Function (Tables)
35 Segment Information
35 Segment Information (Details 1)
35 Segment Information (Details Narrative)
35 Segment Information (Details)
35 Segment Information (Tables)
36 Insurance Coverage (Unaudited)
36 Insurance Coverage (Unaudited) (Details)
36 Insurance Coverage (Unaudited) (Tables)
37 Subsequent Events
37 Subsequent Events (Details Narrative)
4 Risk Management
4 Risk Management (Details)
4 Risk Management (Tables)
4. Risk Management (Details Narrative)
5 Cash And Cash Equivalents
5 Cash And Cash Equivalents (Details Narrative)
5 Cash And Cash Equivalents (Details)
5 Cash And Cash Equivalents (Tables)
6 Financial Investments
6 Financial Investments (Details Narrative)
6 Financial Investments (Details)
6 Financial Investments (Tables)
7 Trade Accounts Receivable
7 Trade Accounts Receivable (Details 1)
7 Trade Accounts Receivable (Details 2)
7 Trade Accounts Receivable (Details 3)
7 Trade Accounts Receivable (Details Narrative)
7 Trade Accounts Receivable (Details)
7 Trade Accounts Receivable (Tables)
8 Inventories
8 Inventories (Details 1)
8 Inventories (Details)
8 Inventories (Tables)
9 Related Parties
9 Related Parties (Details 1)
9 Related Parties (Details Narrative)
9 Related Parties (Details)
9 Related Parties (Tables)
Ticker: BAK
CIK: 1071438
Form Type: 20-F Annual Report
Accession Number: 0001292814-21-002286
Submitted to the SEC: Thu May 13 2021 9:17:12 PM EST
Accepted by the SEC: Fri May 14 2021
Period: Thursday, December 31, 2020
Industry: Industrial Organic Chemicals

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/bak/0001292814-21-002286.htm